TB-Related Articles

 

Journal Articles Published by Division of TB Elimination (DTBE) Authors

2014 DTBE journal articles

Anderson L, Tollefson D, Bloss E, Armstrong L, Yelk Woodruff R, van den Hof S. Chapter 3. Analysis of genotyping data and outbreak investigations. In: Understanding and Using Tuberculosis Data. Luxembourg: WHO; 2014. WHO/HTM/TB/2014.09.
 

Baker BJ, Jeffries CD, Moonan PK. Decline in tuberculosis among Mexico-born persons in the United States, 2000-2010. Ann Am Thorac Soc 2014 May;11(4):480-8. doi:10.1513/AnnalsATS.201402-065OC.

Baker BJ, Moonan PK. Characterizing tuberculosis genotype clusters along the United States–Mexico border. [Short communication.] The International Journal of Tuberculosis and Lung Disease 2014 March 1; 18 (3): 289-291.

Bamrah S, Brostrom R, Dorina F, Setik L, Song R, Kawamura LM, Heetderks A, Mase S. Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009–2012. Int J Tuberc Lung Dis 2014 18(8):912–918. http://dx.doi.org/10.5588/ijtld.13.0028

Bamrah S, Desmond E, Ghosh S, France AM, Kammerer JS, Cowan LS, Heetderks A, Forbes A, Moonan PK. Molecular epidemiology of Mycobacterium tuberculosis in the United States-affiliated Pacific Islands. Asia Pac J Public Health 2014 Jan; 26(1):77-84. http://aph.sagepub.com/content/26/1/77.long

Bansal AK, Kulshrestha N, Nagaraja SB, Rade K, Choudhary A, Parmar M, Nair SA, Dewan PK, Yadav R, Moonan PK. Composite indicator: new tool for monitoring RNTCP performance in India. Int J Tuberc Lung Dis 2014 Jul;18(7):840-2. www.ncbi.nlm.nih.gov/pubmed/24902562

Berzkalns A, Bates J, Ye W, Mukasa L, France AM, et al. The road to tuberculosis (Mycobacterium tuberculosis) elimination in Arkansas; a re-examination of risk groups. PLoS One 2014; 9(3): e90664. doi:10.1371/journal.pone.0090664.

Bharaswadkar S, Kanchar A, Thakur N, Shah S, Patnaik B, Click ES, Kumar AM, Dewan PK. Tuberculosis management practices of private practitioners in Pune Municipal Corporation, India. PLoS One 2014; 9(6): e97993. doi:10.1371/journal.pone.0097993.

Blaya JA, Shin SS, Yagui M, Contreras C, Cegielski P, Yale G, Suarez C, Asencios L, Bayona J, Kim J, Fraser HS. Reducing communication delays and improving quality of care with a tuberculosis laboratory information system in resource poor environments: a cluster randomized controlled trial. PLoS One 2014 Apr 10;9(4):e90110. doi: 10.1371/ journal.pone.0090110.

Bloss E, Ershova J, van den Hof S, Law I, Mitchell E, Tollefson D. Chapter 1. Analysis of aggregated tuberculosis notification data. In: Understanding and Using Tuberculosis Data. Luxembourg: WHO; 2014. WHO/HTM/TB/2014.09.

Bloss E, Yelk Woodruff R, Tollefson D, van den Hof S, Armstrong L, Anderson L. Chapter 2. Analysis of case-based TB notification data. In: Understanding and Using Tuberculosis Data. Luxembourg: WHO; 2014. WHO/HTM/TB/2014.09.

CDC (Alami NN, Yuen CM, Miramontes R, Pratt R, Price SF, Navin TR.) Trends in tuberculosis - United States, 2013. MMWR 2014 Mar 21; 63(11): 229-33.

CDC (Borchert JN, Tappero JW, Downing R, Shoemaker T, Behumbiize P, Aceng J, Makumbi I, Dahlke M, Jarrar B, Lozano B, Kasozi S, Austin M, Phillippe D, Watson ID, Evans TJ, Stotish T, Dowell SF, Iademarco MF, Ransom R, Balajee A, Becknell K, Beauvais D, Wuhib T.) Rapidly building global health security capacity - Uganda demonstration project, 2013. MMWR 2014 Jan 31;63(4):73-6.

CDC (Richardson-Smith N.) World TB Day — March 24, 2014 . MMWR 2014 Mar 21;63 (11):229.

CDC (Tran PD, Vu LN, Nguyen HT, Phan LT, Lowe W, McConnell MS, Iademarco MF, Partridge JM, Kile JC, Do T, Nadol PJ, Bui H, Vu D, Bond K, Nelson DB, Anderson L, Hunt KV, Smith N, Giannone P, Klena J, Beauvais D, Becknell K, Tappero JW, Dowell SF, Rzeszotarski P, Chu M, Kinkade C.) Strengthening global health security capacity - Vietnam demonstration project, 2013. MMWR 2014 Jan 31;63(4):77-80.

CDC (Vernon A.) Announcement: Updated guidelines on managing drug interactions in the treatment of HIV-related tuberculosis. MMWR 2014 Mar 28;63(12):272.

Cegielski JP, Dalton T, Yagui M, Wattanaamornkiet W, Volchenkov GV, Via LE, Van Der Walt M, Tupasi T, Smith SE, Odendaal R, Leimane V, Kvasnovsky C, Kuznetsova T, Kurbatova E, Kummik T, Kuksa L, Kliiman K, Kiryanova EV, Kim H, Kim CK, Kazennyy BY, Jou R, Huang WL, Ershova J, Erokhin VV, Diem L, Contreras C, Cho SN, Chernousova LN, Chen MP, Caoili JC, Bayona J, Akksilp S; the Global PETTS Investigators. Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis. Clin Infect Dis. 2014 Jul 23. pii: ciu572. [Epub ahead of print.]

Chuke SO, Yen NT, Laserson KF, Phuoc NH, Trinh NA, Nhung DT, Mai VT, Qui AD, Hai HH, Loan le TH, Jones WG, Whitworth WC, Shah JJ, Painter JA, Mazurek GH, Maloney SA. Tuberculin skin tests versus interferon-gamma release assays in tuberculosis screening among immigrant visa applicants. Tuberc Res Treat 2014; 2014:217969. doi: 10.1155/2014/217969. [Epub 2014 Mar 6.]

Coleman MS, Marienau KJ, Marano N, Marks SM, Cetron MS. Economics of United States tuberculosis airline contact investigation policies: a return on investment analysis. Travel Med Infect Dis 2014 Jan-Feb;12(1):63-71.

Cruz AT, Starke JR, Lobato MN. Old and new approaches to diagnosing and treating latent tuberculosis in children in low-incidence countries. Curr Opin Pediatr 2013 Dec 2. [Epub ahead of print.]

Davis JL, Kawamura LM, Chaisson LH, Grinsdale J, Benhammou J, Ho C, Babst A, Banouvong H, Metcalfe JZ, Pandori M, Hopewell PC, Cattamanchi A. Impact of GeneXpert MTB/RIF on patients and tuberculosis programs in a low-burden setting. A hypothetical trial. Am J Respir Crit Care Med. 2014 Jun 15;189(12):1551-9. doi: 10.1164/rccm.201311-1974OC

De Beer JL, Kodmon C, Van Ingen J, Jamieson FB, Bidovec-Stojkovic U, Brown T, Cirillo DM, Cruz L, Miranda A, Dou HY, Fauville-Dufaux M, Fitzgibbon MM, Garcia De Viedma D, Groenheit R, Haanpera-Heikkinen M, Indra A, Kam KM, Kramer R, Jiang GL, Niemann S, Obrovac M, Rasmussen EM, Refregier G, Realpe T, Samper S, Sharma MK, Sougakoff W, Stakenas P, Stavrum R, Trenkler J, Wada T, Siame KK, Tafaj S, Cowan L, Sng LH, Seagar AL, Basu I, Rastogi N, Ferro BE, De Matos F, Kipnis A, Van Soolingen D, Supply P. Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis 2014 01 May;18(5):594-600+i.

Defang RR, Brostrom R, Ram S, Johnson E, Perman PS. Screening for tuberculosis and LTBI in diabetes patients, Pohnpei, Federated States of Micronesia. Public Health Action 2014 June 21; 4 (Suppl 1): S53-S55.

Duraisamy K, Mrithyunjayan S, Ghosh S, Nair SA, Balakrishnan S, Subramoniapillai J, Oeltmann JE, Moonan PK, Kumar AM. Does alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome? A population-based study in Kerala, India. Ann Am Thorac Soc. 2014 Jun;11(5):712-8.

Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, Parker M, Garrett DO, Daley CL. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med 2014; 189 (1): 77-87. doi: 10.1164/rccm.201302-0365OC

Egelund EF, Weiner M, Singh RP, Prihoda TJ, Gelfond JA, Derendorf H, Mac Kenzie WR, Peloquin CA. Protein binding of rifapentine and the 25-desacetyl metabolite in patients with pulmonary tuberculosis. Antimicrob Agents Chemother. 2014 May 19. pii: AAC.01730-13. [Epub ahead of print.]

Elmore K, Nelson R, Gant Z, Jeffries C, Broeker L, Mirabito M, Roberts H. Data harmonization process for creating the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Atlas. Public Health Rep 2014 Jan-Feb;129 Suppl 1:63-9.

Ershova JV, Kurbatova EV, Moonan PK, Cegielski JP, et al. Mortality among tuberculosis patients with acquired resistance to second-line anti-tuberculosis drugs — United States, 1993-2008. Clin Infect Dis 2014. [E-pub ahead of print May 20, 2014.]

Ershova JV, Podewils LJ, Bronner E, Stockwell HG, Dlamini S, Mametja LD. Evaluation of adherence to national treatment guidelines among tuberculosis patients in three provinces of South Africa. S Afr Med J 2014 ;104(5):362-368.

Fiske CT, Yan F-X, Hirsch-Moverman Y, Sterling TR, Reichler MR, for the Tuberculosis Epidemiologic Studies Consortium Task Order 2 Team. Risk factors for treatment default in close contacts with latent tuberculous infection. The International Journal of Tuberculosis and Lung Disease 2014 Apr 1; 18 (4): 421-427.

Girin N, Brostrom R, Ram S, McKenzie J, Kumar AM, Roseveare C. Describing the burden of non-communicable disease risk factors among adults with diabetes in Wallis and Futuna. Public Health Action 2014 01 Jun;4(Suppl 1):S39-S43.

Goodwin DJ, Mazurek GH, Campbell BH, Bohanon J, West KB, Bell JJ, Powell R, Toney S, Morris JA, Yamane GK, Sjoberg PA. Automation of an Interferon-γ release assay and comparison to the tuberculin skin test for screening basic military trainees for Mycobacterium tuberculosis infection. Military Medicine 2014 March; 179 (3): 333-341. doi: http://dx.doi.org/10.7205/MILMED-D-13-00364.

Graham SM, Sismanidis C, Menzies HJ, Marais BJ, Detjen AK, Black RE. Importance of tuberculosis control to address child survival. Lancet 2014 May 3;383(9928):1605-7. doi: 10.1016/S0140-6736(14)60420-7.

Heilig CM, Feng PJ, Joloba ML, Johnson JL, Morgan K, Gitta P, Boom WH, Mayanja-Kizza H, Eisenach KD, Bozeman L, Goldberg SV. How we determined the most reliable solid medium for studying treatment of tuberculosis. Tuberculosis (Edinb) 2014 May;94(3):317-22. doi: 10.1016/j.tube.2014.02.006.

Joloba ML, Johnson JL, Feng PJ, Bozeman L, Goldberg SV, Morgan K, Gitta P, Boom HW, Heilig CM, Mayanja-Kizza H, Eisenach KD. What is the most reliable solid culture medium for tuberculosis treatment trials? Tuberculosis (Edinb). 2014 May;94(3):311-6. doi: 10.1016/ j.tube.2014.03.002.

Kong D, Watt JP, Marks SM, Flood JM. Timely HIV diagnosis and HIV/TB comanagement among California patients in 2008. Public Health Rep 2014 Mar; 129(2):170-7.

Lam E, Nateniyom S, Whitehead S, Anuwatnonthakate A, Monkongdee P, Kanphukiew A, Inyaphong J, Sitti W, Chiengsorn N, Moolphate S, Kavinum S, Suriyon N, Limsomboon P, Danyutapolchai J, Sinthuwattanawibool C, Podewils LJ. Use of drug-susceptibility testing for management of drug-resistant tuberculosis, Thailand, 2004-2008. Emerg Infect Dis 2014 Mar;20(3):408-16.

Marienau KJ, Cramer EH, Coleman MS, Marano N, Cetron MS. Flight related tuberculosis contact investigations in the United States: Comparative risk and economic analysis of alternate protocols. Travel Med Infect Dis 2014 Jan-Feb;12(1):54-62. doi: 10.1016/j.tmaid.2013.09.007.

Marks SM, Flood J, Seaworth B, Hirsch-Moverman Y, Armstrong L, Mase S, et al. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005–2007. Emerg Infect Dis [Internet] 2014 May. http://dx.doi.org/10.3201/eid2005.131037. DOI: 10.3201/eid2005.131037

Medrano BA, Salinas G, Sanchez C, Miramontes R, Restrepo BI, Haddad MB, Lambert LA. A missed tuberculosis diagnosis resulting in hospital transmission. Infect Control Hosp Epidemiol 2014 May;35(5):534-7.

Mitruka K, Blake H, Ricks P, Miramontes R, Bamrah S, Chee C, Hickstein L. A tuberculosis outbreak fueled by cross-border travel and illicit substances: Nevada and Arizona. Public Health Reports 2014 Jan-Feb; 129:78-85.

Mortensen E, Hellinger W, Keller C, Cowan LS, Shaw T, Hwang S, Pegues D, Ahmedov S, Salfinger M, Bower WA. Three cases of donor-derived pulmonary tuberculosis in lung transplant recipients and review of 12 previously reported cases: opportunities for early diagnosis and prevention. Transpl Infect Dis 2014 Feb;16(1):67-75. doi: 10.1111/tid.12171.

Nahid P, Bliven-Sizemore E, Jarlsberg LG, De Groote MA, Johnson JL, Muzanyi G, Engle M, Weiner M, Janjic N, Sterling DG, Ochsner UA. Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis. Tuberculosis (Edinb) 2014 May;94(3):187-96. doi: 10.1016/j.tube.2014.01.006.

Nasa JN, Brostrom R, Ram S, Kumar AM, Seremai J, Hauma M, Paul IA, Langidrik JR. Screening adult tuberculosis patients for diabetes mellitus in Ebeye, Republic of the Marshall Islands. Public Health Action 2014 June 21; 4 (Suppl 1): S50-S52.

Oeltmann JE, Click ES, Moonan PK. Using tuberculosis patient characteristics to predict future cases with matching genotype results. Public Health Action 2014 Mar; 4(1): 47-52.

Pang J, Teeter LD, Katz DJ, Davidow AL, Miranda W, Wall K, Ghosh S, Stein-Hart T, Restrepo BI, Reves R, Graviss EA; on behalf of the Tuberculosis Epidemiologic Studies Consortium. Epidemiology of tuberculosis in young children in the United States. Pediatrics 2014 Mar; 133(3):e494-504. doi: 10.1542/peds.2013-2570.

Parija D, Patra TK, Kumar AMV, Swain BK, Satyanarayana S, Sreenivas A, Chadha VK, Moonan PK, Oeltmann JE. Impact of awareness drives and community-based active tuberculosis case finding in Odisha, India. Int J Tuberc Lung Dis 2014 Sep;18(9):1011-3.

Pascopella L, Franks J, Marks SM, Salcedo K, Schmitz K, Colson PW, Hirsch-Moverman Y, Flood J, Sayles J. Opportunities for tuberculosis diagnosis and prevention among persons living with HIV: a cross-sectional study of policies and practices at four large Ryan White program-funded HIV clinics. PLoS One. 2014 Jul 7;9(7):e101313. doi: 10.1371/journal.pone.0101313. eCollection 2014.

Podewils LJ, Alexy E, Driver SJ, Cheek JE, Holman RC, Haberling D, Brett M, McCray E, Redd JT. Understanding the burden of tuberculosis among American Indians/Alaska Natives in the U.S.: a validation study. Public Health Rep. 2014 Jul;129(4):351-60.

Reilley B, Bloss E, Byrd KK, Iralu J, Neel L, and Cheek J. Death rates from human immunodeficiency virus and tuberculosis among American Indians/Alaska Natives in the United States, 1990–2009. American Journal of Public Health 2014 June (supplement); 104 (S3): S453-S459. doi: 10.2105/AJPH.2013.301746.

Reves R, Heilig CM, Tapy JM, Bozeman L, Kyle RP, Dukes Hamilton C, Bock N, Narita M, D. Wing, Hershfield E, Goldberg SV, for the Tuberculosis Trials Consortium. Intermittent tuberculosis treatment for patients with isoniazid intolerance or drug resistance. IJTLD 2014 May 1; 18 (5): 571-580.

Savic RM, Lu Y, Bliven-Sizemore E, Weiner M, Nuermberger E, Burman W, Dorman SE, Dooley KE. Population pharmacokinetics of rifapentine and desacetyl rifapentine in healthy volunteers: nonlinearities in clearance and bioavailability. Antimicrob Agents Chemother 2014 Jun;58(6):3035-3042.

Shah NS, Yuen CM, Heo M, Tolman AW, Becerra MC. Yield of contact investigations in households of patients with drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis 2014; 58 (3): 381-391. doi:10.1093/cid/cit643.

Shea KM, Kammerer JS, Winston CA, Navin TR, Horsburgh CR Jr. Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup. Am J Epidemiol 2014 Jan 15;179(2):216-25. doi: 10.1093/aje/kwt246.

Shivaramakrishna HR, Frederick A, Shazia A, Murali L, Satyanarayana S, Nair SA, Kumar AM, Moonan PK. Isoniazid preventive treatment in children in two districts of South India: does practice follow policy? Int J Tuberc Lung Dis 2014 August 1; 18(8):919–924. http://dx.doi.org/10.5588/ijtld.14.0072.

Sismanidis C, Mitchell E, Law I, Bloss E, Glaziou P. Chapter 4. Analysis of factors driving the tuberculosis epidemic. In: Understanding and Using Tuberculosis Data. Luxembourg: WHO; 2014. WHO/HTM/TB/2014.09.
 

Suryaprasad A, Redd JT, Ricks PM, Podewils LJ, Brett M, Oski J, Minenna W, Armao F, Vize BJ, Cheek JE. Effect of rapid influenza diagnostic testing on antiviral treatment decisions for patients with influenza-like illness: southwestern U.S, May-December 2009. Public Health Rep 2014 Jul;129(4):322-7.

Walter ND, Painter J, Parker M, Lowenthal P, Flood J, Fu Y, Asis R, Reves R. Persistent latent tuberculosis reactivation risk in United States immigrants. Am J Respir Crit Care Med 2014; 189 (1): 88-95.

Weiner M, Egelund EF, Engle M, Kiser M, Prihoda TJ, Gelfond JAL, Mac Kenzie WM, Peloquin CA. Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers. J Antimicrob Chemother 2014; doi:10.1093/jac/dkt483.

Weiner M, Savic RM, Mac Kenzie WR, Wing D, Peloquin CA, Engle M, Bliven E, Prihoda TJ, Gelfond JAL, Scott NA, Abdel-Rahman SM, Kearns GL, Burman WJ, Sterling TR, Villarino ME, for the Tuberculosis Trials Consortium PREVENT TB Pharmacokinetic Group. Rifapentine pharmacokinetics and tolerability in children and adults treated once weekly with rifapentine and isoniazid for latent tuberculosis infection. J Ped Infect Dis 2014 3: 132-145.

Whitworth WC, Goodwin DJ, Racster L, West KB, Chuke SO, Daniels LJ, Campbell BH, Bohanon J, Jaffar AT, Drane W, Sjoberg PA, Mazurek GH. Variability of the QuantiFERON(R)-TB Gold In-Tube test using automated and manual methods. PLoS One 2014 Jan 23; 9(1): e86721.

Yakrus MA, Driscoll J, Lentz AJ, Sikes D, Hartline D, Metchock B, Starks AM. Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States. J Clin Microbiol 2014; doi:10.1128/JCM.00417-14.

Yuen CM, Weyenga HO, Kim AA, Malika T, Muttai H, Katana A, Nganga L, Cain KP, De Cock KM. Comparison of trends in tuberculosis incidence among adults living with HIV and adults without HIV - Kenya, 1998-2012. PLoS One. 2014 Jun 17;9(6):e99880. doi: 10.1371/journal.pone.0099880. eCollection 2014.

Zetola NM, Modongo C, Moonan PK, Ncube R, Matlhagela K, Sepako E, Collman RG, Bisson GP. Clinical outcomes among persons with pulmonary tuberculosis disease caused by M. tuberculosis isolates with phenotypic DST heterogeneity. J Infect Dis 2014 Jun;209(11):1754-63. PubMed PMID: 24443546. http://jid.oxfordjournals.org/content/early/2014/01/16/infdis.jiu040.abstract?sid=a485531f-356f-418e-854c-1b72620e6551